nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—SLC22A1—hematologic cancer	0.165	1	CbGaD
Nicotine—CYP2A13—Methoxsalen—hematologic cancer	0.124	0.232	CbGbCtD
Nicotine—SLC22A3—Melphalan—hematologic cancer	0.0274	0.0514	CbGbCtD
Nicotine—SLC22A2—Daunorubicin—hematologic cancer	0.0115	0.0215	CbGbCtD
Nicotine—SLC22A2—Cytarabine—hematologic cancer	0.0101	0.019	CbGbCtD
Nicotine—CYP2A6—Methoxsalen—hematologic cancer	0.0101	0.0189	CbGbCtD
Nicotine—SLC22A2—Cladribine—hematologic cancer	0.00956	0.0179	CbGbCtD
Nicotine—SLC22A3—Irinotecan—hematologic cancer	0.00928	0.0174	CbGbCtD
Nicotine—SLC22A1—Cytarabine—hematologic cancer	0.0088	0.0165	CbGbCtD
Nicotine—SLC22A2—Imatinib—hematologic cancer	0.00879	0.0165	CbGbCtD
Nicotine—CYP1A2—Anagrelide—hematologic cancer	0.0086	0.0161	CbGbCtD
Nicotine—CYP1A1—Methoxsalen—hematologic cancer	0.0086	0.0161	CbGbCtD
Nicotine—CYP2B6—Thiotepa—hematologic cancer	0.00842	0.0158	CbGbCtD
Nicotine—SLC22A1—Cladribine—hematologic cancer	0.00831	0.0156	CbGbCtD
Nicotine—CYP1A1—Bortezomib—hematologic cancer	0.00818	0.0153	CbGbCtD
Nicotine—SLC22A3—Vincristine—hematologic cancer	0.00811	0.0152	CbGbCtD
Nicotine—CYP19A1—Betamethasone—hematologic cancer	0.00783	0.0147	CbGbCtD
Nicotine—CYP1A1—Daunorubicin—hematologic cancer	0.00782	0.0147	CbGbCtD
Nicotine—SLC22A1—Imatinib—hematologic cancer	0.00764	0.0143	CbGbCtD
Nicotine—CYP2A6—Ifosfamide—hematologic cancer	0.00734	0.0138	CbGbCtD
Nicotine—CHRFAM7A—ovarian follicle—hematologic cancer	0.00713	0.125	CbGeAlD
Nicotine—CYP1A1—Thalidomide—hematologic cancer	0.00712	0.0134	CbGbCtD
Nicotine—CYP1A1—Dacarbazine—hematologic cancer	0.00613	0.0115	CbGbCtD
Nicotine—CHRNA7—ovarian follicle—hematologic cancer	0.00576	0.101	CbGeAlD
Nicotine—CYP2E1—Thalidomide—hematologic cancer	0.0055	0.0103	CbGbCtD
Nicotine—CYP2C9—Bexarotene—hematologic cancer	0.00537	0.0101	CbGbCtD
Nicotine—CYP2A6—Prednisolone—hematologic cancer	0.00489	0.00918	CbGbCtD
Nicotine—SLC22A2—Vinblastine—hematologic cancer	0.00488	0.00916	CbGbCtD
Nicotine—CYP1A1—Dasatinib—hematologic cancer	0.00481	0.00903	CbGbCtD
Nicotine—CYP2B6—Ifosfamide—hematologic cancer	0.00478	0.00896	CbGbCtD
Nicotine—CYP2E1—Dacarbazine—hematologic cancer	0.00473	0.00888	CbGbCtD
Nicotine—CYP2C8—Bortezomib—hematologic cancer	0.00472	0.00885	CbGbCtD
Nicotine—CYP2D6—Lomustine—hematologic cancer	0.00456	0.00856	CbGbCtD
Nicotine—CYP19A1—Dexamethasone—hematologic cancer	0.00455	0.00854	CbGbCtD
Nicotine—CYP1A2—Carmustine—hematologic cancer	0.00452	0.00847	CbGbCtD
Nicotine—CYP19A1—ovarian follicle—hematologic cancer	0.00451	0.0793	CbGeAlD
Nicotine—SLC22A2—Cisplatin—hematologic cancer	0.00448	0.0084	CbGbCtD
Nicotine—CYP2C9—Idarubicin—hematologic cancer	0.00445	0.00835	CbGbCtD
Nicotine—CYP2B6—Nilotinib—hematologic cancer	0.00415	0.00778	CbGbCtD
Nicotine—CYP2D6—Idarubicin—hematologic cancer	0.00407	0.00763	CbGbCtD
Nicotine—CYP2C19—Bortezomib—hematologic cancer	0.00396	0.00743	CbGbCtD
Nicotine—CYP1A2—Methoxsalen—hematologic cancer	0.00384	0.0072	CbGbCtD
Nicotine—CYP2E1—Mitoxantrone—hematologic cancer	0.00367	0.00689	CbGbCtD
Nicotine—CYP1A2—Bortezomib—hematologic cancer	0.00365	0.00685	CbGbCtD
Nicotine—CYP2C8—Ifosfamide—hematologic cancer	0.00362	0.00679	CbGbCtD
Nicotine—CYP1A2—Daunorubicin—hematologic cancer	0.00349	0.00655	CbGbCtD
Nicotine—CYP2D6—Hydroxyurea—hematologic cancer	0.00346	0.00649	CbGbCtD
Nicotine—CYP2C19—Thalidomide—hematologic cancer	0.00345	0.00647	CbGbCtD
Nicotine—CYP1A2—Alitretinoin—hematologic cancer	0.00342	0.00642	CbGbCtD
Nicotine—CYP2C9—Bortezomib—hematologic cancer	0.00329	0.00617	CbGbCtD
Nicotine—CYP2C19—Teniposide—hematologic cancer	0.00329	0.00617	CbGbCtD
Nicotine—CYP1A2—Thalidomide—hematologic cancer	0.00318	0.00597	CbGbCtD
Nicotine—CYP2C8—Nilotinib—hematologic cancer	0.00314	0.00589	CbGbCtD
Nicotine—CYP3A4—Bexarotene—hematologic cancer	0.00312	0.00586	CbGbCtD
Nicotine—CYP2C19—Ifosfamide—hematologic cancer	0.00304	0.0057	CbGbCtD
Nicotine—CYP2D6—Bortezomib—hematologic cancer	0.00301	0.00565	CbGbCtD
Nicotine—CYP3A4—Lomustine—hematologic cancer	0.0029	0.00545	CbGbCtD
Nicotine—CYP3A4—Busulfan—hematologic cancer	0.0029	0.00545	CbGbCtD
Nicotine—CYP2C19—Imatinib—hematologic cancer	0.0029	0.00544	CbGbCtD
Nicotine—CYP2A6—Dexamethasone—hematologic cancer	0.00288	0.00541	CbGbCtD
Nicotine—CYP2C9—Thalidomide—hematologic cancer	0.00287	0.00538	CbGbCtD
Nicotine—CYP2B6—Irinotecan—hematologic cancer	0.00285	0.00535	CbGbCtD
Nicotine—CYP1A2—Dacarbazine—hematologic cancer	0.00274	0.00513	CbGbCtD
Nicotine—CYP2C9—Teniposide—hematologic cancer	0.00274	0.00513	CbGbCtD
Nicotine—CYP1A2—Imatinib—hematologic cancer	0.00268	0.00502	CbGbCtD
Nicotine—CYP3A4—Thiotepa—hematologic cancer	0.00259	0.00485	CbGbCtD
Nicotine—CYP2C9—Ifosfamide—hematologic cancer	0.00252	0.00474	CbGbCtD
Nicotine—CYP1A1—Dexamethasone—hematologic cancer	0.00246	0.00462	CbGbCtD
Nicotine—CYP2C9—Imatinib—hematologic cancer	0.00241	0.00452	CbGbCtD
Nicotine—CYP2B6—Cisplatin—hematologic cancer	0.00232	0.00436	CbGbCtD
Nicotine—CYP2E1—Etoposide—hematologic cancer	0.00232	0.00434	CbGbCtD
Nicotine—CYP2D6—Imatinib—hematologic cancer	0.00221	0.00414	CbGbCtD
Nicotine—CYP2C9—Nilotinib—hematologic cancer	0.00219	0.00411	CbGbCtD
Nicotine—CYP1A2—Dasatinib—hematologic cancer	0.00215	0.00403	CbGbCtD
Nicotine—CYP3A4—Methoxsalen—hematologic cancer	0.00201	0.00377	CbGbCtD
Nicotine—CYP2D6—Nilotinib—hematologic cancer	0.002	0.00376	CbGbCtD
Nicotine—CYP2D6—Vinorelbine—hematologic cancer	0.00199	0.00373	CbGbCtD
Nicotine—CYP3A4—Bortezomib—hematologic cancer	0.00191	0.00359	CbGbCtD
Nicotine—CYP2C19—Prednisone—hematologic cancer	0.00191	0.00359	CbGbCtD
Nicotine—CYP2E1—Dexamethasone—hematologic cancer	0.0019	0.00357	CbGbCtD
Nicotine—CYP2B6—Dexamethasone—hematologic cancer	0.00188	0.00352	CbGbCtD
Nicotine—CYP3A4—Daunorubicin—hematologic cancer	0.00183	0.00343	CbGbCtD
Nicotine—CYP2C8—Etoposide—hematologic cancer	0.00173	0.00324	CbGbCtD
Nicotine—CYP2A13—lung—hematologic cancer	0.00171	0.03	CbGeAlD
Nicotine—CYP3A4—Cytarabine—hematologic cancer	0.00161	0.00303	CbGbCtD
Nicotine—CYP3A4—Teniposide—hematologic cancer	0.00159	0.00298	CbGbCtD
Nicotine—CHAT—hematopoietic system—hematologic cancer	0.00159	0.0279	CbGeAlD
Nicotine—CYP2B6—Doxorubicin—hematologic cancer	0.00156	0.00292	CbGbCtD
Nicotine—CHRNA10—hematopoietic system—hematologic cancer	0.00153	0.0268	CbGeAlD
Nicotine—CYP3A4—Ifosfamide—hematologic cancer	0.00147	0.00275	CbGbCtD
Nicotine—CYP2C8—Dexamethasone—hematologic cancer	0.00142	0.00267	CbGbCtD
Nicotine—CYP3A4—Imatinib—hematologic cancer	0.0014	0.00263	CbGbCtD
Nicotine—CHRNA5—testis—hematologic cancer	0.00138	0.0243	CbGeAlD
Nicotine—CYP1A2—Etoposide—hematologic cancer	0.00134	0.00251	CbGbCtD
Nicotine—CYP3A4—Ruxolitinib—hematologic cancer	0.00132	0.00248	CbGbCtD
Nicotine—CYP3A4—Nilotinib—hematologic cancer	0.00127	0.00239	CbGbCtD
Nicotine—CYP3A4—Vinorelbine—hematologic cancer	0.00126	0.00237	CbGbCtD
Nicotine—CYP2C9—Cisplatin—hematologic cancer	0.00123	0.0023	CbGbCtD
Nicotine—CYP2D6—Vinblastine—hematologic cancer	0.00122	0.0023	CbGbCtD
Nicotine—CYP2C19—Dexamethasone—hematologic cancer	0.00119	0.00224	CbGbCtD
Nicotine—CYP3A4—Triamcinolone—hematologic cancer	0.00116	0.00217	CbGbCtD
Nicotine—CYP3A4—Dasatinib—hematologic cancer	0.00113	0.00211	CbGbCtD
Nicotine—CYP3A4—Mitoxantrone—hematologic cancer	0.00111	0.00209	CbGbCtD
Nicotine—CHRNA3—hematopoietic system—hematologic cancer	0.00106	0.0187	CbGeAlD
Nicotine—CHAT—blood—hematologic cancer	0.00105	0.0185	CbGeAlD
Nicotine—CHRNA10—blood—hematologic cancer	0.00101	0.0178	CbGeAlD
Nicotine—CHRNA5—lymph node—hematologic cancer	0.001	0.0176	CbGeAlD
Nicotine—CYP2C9—Dexamethasone—hematologic cancer	0.000992	0.00186	CbGbCtD
Nicotine—CYP3A4—Betamethasone—hematologic cancer	0.000991	0.00186	CbGbCtD
Nicotine—CYP3A4—Prednisolone—hematologic cancer	0.000978	0.00184	CbGbCtD
Nicotine—CHRNB4—testis—hematologic cancer	0.000951	0.0167	CbGeAlD
Nicotine—CYP3A4—Prednisone—hematologic cancer	0.000924	0.00173	CbGbCtD
Nicotine—CYP2D6—Dexamethasone—hematologic cancer	0.000907	0.0017	CbGbCtD
Nicotine—CYP3A4—Irinotecan—hematologic cancer	0.000876	0.00164	CbGbCtD
Nicotine—CHRFAM7A—hematopoietic system—hematologic cancer	0.000861	0.0151	CbGeAlD
Nicotine—CHRNA10—testis—hematologic cancer	0.000837	0.0147	CbGeAlD
Nicotine—CYP3A4—Vinblastine—hematologic cancer	0.000779	0.00146	CbGbCtD
Nicotine—CYP3A4—Vincristine—hematologic cancer	0.000765	0.00144	CbGbCtD
Nicotine—CYP2D6—Doxorubicin—hematologic cancer	0.000752	0.00141	CbGbCtD
Nicotine—CHRNB2—blood—hematologic cancer	0.000727	0.0128	CbGeAlD
Nicotine—CHRNB2—bone marrow—hematologic cancer	0.000704	0.0124	CbGeAlD
Nicotine—CYP3A4—Etoposide—hematologic cancer	0.000701	0.00132	CbGbCtD
Nicotine—CHRNA7—hematopoietic system—hematologic cancer	0.000695	0.0122	CbGeAlD
Nicotine—CHRNA4—hematopoietic system—hematologic cancer	0.000686	0.0121	CbGeAlD
Nicotine—CHRNA2—blood—hematologic cancer	0.000656	0.0115	CbGeAlD
Nicotine—CHRNB2—lung—hematologic cancer	0.000637	0.0112	CbGeAlD
Nicotine—CHRNA3—lung—hematologic cancer	0.000618	0.0109	CbGeAlD
Nicotine—CHRNA10—lymph node—hematologic cancer	0.000607	0.0107	CbGeAlD
Nicotine—CHRNB2—testis—hematologic cancer	0.000601	0.0106	CbGeAlD
Nicotine—CHRNA3—testis—hematologic cancer	0.000583	0.0102	CbGeAlD
Nicotine—CYP3A4—Dexamethasone—hematologic cancer	0.000577	0.00108	CbGbCtD
Nicotine—CHRFAM7A—blood—hematologic cancer	0.00057	0.01	CbGeAlD
Nicotine—SLC22A3—hematopoietic system—hematologic cancer	0.000554	0.00974	CbGeAlD
Nicotine—CYP19A1—hematopoietic system—hematologic cancer	0.000545	0.00957	CbGeAlD
Nicotine—MAOB—hematopoietic system—hematologic cancer	0.000513	0.00901	CbGeAlD
Nicotine—CYP3A4—Doxorubicin—hematologic cancer	0.000478	0.000898	CbGbCtD
Nicotine—CHRFAM7A—testis—hematologic cancer	0.000472	0.00829	CbGeAlD
Nicotine—CHRNA7—blood—hematologic cancer	0.000461	0.00809	CbGeAlD
Nicotine—CYP2C19—hematopoietic system—hematologic cancer	0.000447	0.00785	CbGeAlD
Nicotine—MAOA—hematopoietic system—hematologic cancer	0.000437	0.00769	CbGeAlD
Nicotine—CHRNB2—lymph node—hematologic cancer	0.000436	0.00766	CbGeAlD
Nicotine—CHRNA3—lymph node—hematologic cancer	0.000423	0.00743	CbGeAlD
Nicotine—SLC22A3—gonad—hematologic cancer	0.000421	0.0074	CbGeAlD
Nicotine—CYP19A1—gonad—hematologic cancer	0.000414	0.00728	CbGeAlD
Nicotine—CYP2A6—lung—hematologic cancer	0.000403	0.00709	CbGeAlD
Nicotine—SLC22A4—blood—hematologic cancer	0.000403	0.00709	CbGeAlD
Nicotine—CHRNA4—lung—hematologic cancer	0.000398	0.007	CbGeAlD
Nicotine—SLC22A4—bone marrow—hematologic cancer	0.00039	0.00686	CbGeAlD
Nicotine—CYP2C8—hematopoietic system—hematologic cancer	0.00039	0.00685	CbGeAlD
Nicotine—SLC22A1—blood—hematologic cancer	0.000384	0.00675	CbGeAlD
Nicotine—CHRNA7—testis—hematologic cancer	0.000381	0.00669	CbGeAlD
Nicotine—CYP1A2—hematopoietic system—hematologic cancer	0.000365	0.00641	CbGeAlD
Nicotine—CYP19A1—blood—hematologic cancer	0.000361	0.00634	CbGeAlD
Nicotine—CYP1A1—hematopoietic system—hematologic cancer	0.00036	0.00633	CbGeAlD
Nicotine—SLC22A4—lung—hematologic cancer	0.000354	0.00621	CbGeAlD
Nicotine—CYP2B6—hematopoietic system—hematologic cancer	0.00035	0.00615	CbGeAlD
Nicotine—CYP2C9—hematopoietic system—hematologic cancer	0.000346	0.00609	CbGeAlD
Nicotine—MAOB—blood—hematologic cancer	0.00034	0.00597	CbGeAlD
Nicotine—CYP2E1—hematopoietic system—hematologic cancer	0.000328	0.00577	CbGeAlD
Nicotine—SLC22A3—lung—hematologic cancer	0.000322	0.00565	CbGeAlD
Nicotine—SLC22A3—testis—hematologic cancer	0.000304	0.00534	CbGeAlD
Nicotine—CYP19A1—testis—hematologic cancer	0.000299	0.00525	CbGeAlD
Nicotine—MAOB—lung—hematologic cancer	0.000298	0.00523	CbGeAlD
Nicotine—CYP2C19—blood—hematologic cancer	0.000296	0.0052	CbGeAlD
Nicotine—MAOA—blood—hematologic cancer	0.00029	0.00509	CbGeAlD
Nicotine—MAOB—testis—hematologic cancer	0.000281	0.00494	CbGeAlD
Nicotine—SLC22A5—blood—hematologic cancer	0.000267	0.00469	CbGeAlD
Nicotine—CYP2B6—gonad—hematologic cancer	0.000266	0.00467	CbGeAlD
Nicotine—CYP3A4—hematopoietic system—hematologic cancer	0.000264	0.00464	CbGeAlD
Nicotine—CYP2D6—hematopoietic system—hematologic cancer	0.00026	0.00457	CbGeAlD
Nicotine—CYP2C8—blood—hematologic cancer	0.000258	0.00454	CbGeAlD
Nicotine—MAOA—lung—hematologic cancer	0.000254	0.00446	CbGeAlD
Nicotine—SLC22A4—lymph node—hematologic cancer	0.000242	0.00425	CbGeAlD
Nicotine—CYP1A2—blood—hematologic cancer	0.000242	0.00425	CbGeAlD
Nicotine—MAOA—testis—hematologic cancer	0.00024	0.00421	CbGeAlD
Nicotine—CYP1A1—blood—hematologic cancer	0.000238	0.00419	CbGeAlD
Nicotine—SLC22A5—lung—hematologic cancer	0.000234	0.00411	CbGeAlD
Nicotine—CYP2B6—blood—hematologic cancer	0.000232	0.00407	CbGeAlD
Nicotine—CYP2C9—blood—hematologic cancer	0.00023	0.00403	CbGeAlD
Nicotine—SLC22A5—testis—hematologic cancer	0.000221	0.00388	CbGeAlD
Nicotine—SLC22A3—lymph node—hematologic cancer	0.00022	0.00387	CbGeAlD
Nicotine—CYP2E1—blood—hematologic cancer	0.000218	0.00382	CbGeAlD
Nicotine—CYP19A1—lymph node—hematologic cancer	0.000216	0.0038	CbGeAlD
Nicotine—CYP2C8—testis—hematologic cancer	0.000214	0.00376	CbGeAlD
Nicotine—CYP1A2—lung—hematologic cancer	0.000212	0.00372	CbGeAlD
Nicotine—CYP1A1—lung—hematologic cancer	0.000209	0.00367	CbGeAlD
Nicotine—MAOB—lymph node—hematologic cancer	0.000204	0.00358	CbGeAlD
Nicotine—CYP2B6—lung—hematologic cancer	0.000203	0.00357	CbGeAlD
Nicotine—CYP2B6—testis—hematologic cancer	0.000192	0.00337	CbGeAlD
Nicotine—CYP2E1—lung—hematologic cancer	0.000191	0.00335	CbGeAlD
Nicotine—CYP2E1—testis—hematologic cancer	0.00018	0.00316	CbGeAlD
Nicotine—CYP3A4—blood—hematologic cancer	0.000175	0.00308	CbGeAlD
Nicotine—MAOA—lymph node—hematologic cancer	0.000174	0.00305	CbGeAlD
Nicotine—CYP2D6—blood—hematologic cancer	0.000172	0.00303	CbGeAlD
Nicotine—SLC22A5—lymph node—hematologic cancer	0.00016	0.00281	CbGeAlD
Nicotine—CYP1A1—lymph node—hematologic cancer	0.000143	0.00251	CbGeAlD
Nicotine—CYP2D6—testis—hematologic cancer	0.000142	0.0025	CbGeAlD
Nicotine—Nausea—Mitoxantrone—hematologic cancer	2e-05	0.000119	CcSEcCtD
Nicotine—Nausea—Irinotecan—hematologic cancer	2e-05	0.000119	CcSEcCtD
Nicotine—Immune system disorder—Epirubicin—hematologic cancer	2e-05	0.000119	CcSEcCtD
Nicotine—Mediastinal disorder—Epirubicin—hematologic cancer	2e-05	0.000119	CcSEcCtD
Nicotine—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.99e-05	0.000119	CcSEcCtD
Nicotine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.99e-05	0.000119	CcSEcCtD
Nicotine—Back pain—Methotrexate—hematologic cancer	1.99e-05	0.000119	CcSEcCtD
Nicotine—Fatigue—Betamethasone—hematologic cancer	1.99e-05	0.000119	CcSEcCtD
Nicotine—Fatigue—Dexamethasone—hematologic cancer	1.99e-05	0.000119	CcSEcCtD
Nicotine—Pruritus—Etoposide—hematologic cancer	1.99e-05	0.000118	CcSEcCtD
Nicotine—Shock—Prednisone—hematologic cancer	1.98e-05	0.000118	CcSEcCtD
Nicotine—Arrhythmia—Epirubicin—hematologic cancer	1.98e-05	0.000118	CcSEcCtD
Nicotine—Pain—Betamethasone—hematologic cancer	1.97e-05	0.000118	CcSEcCtD
Nicotine—Pain—Dexamethasone—hematologic cancer	1.97e-05	0.000118	CcSEcCtD
Nicotine—Visual impairment—Doxorubicin—hematologic cancer	1.97e-05	0.000118	CcSEcCtD
Nicotine—Nervous system disorder—Prednisone—hematologic cancer	1.97e-05	0.000118	CcSEcCtD
Nicotine—Tachycardia—Prednisone—hematologic cancer	1.96e-05	0.000117	CcSEcCtD
Nicotine—Nausea—Gemcitabine—hematologic cancer	1.95e-05	0.000116	CcSEcCtD
Nicotine—Vomiting—Cisplatin—hematologic cancer	1.95e-05	0.000116	CcSEcCtD
Nicotine—Hyperhidrosis—Prednisone—hematologic cancer	1.94e-05	0.000116	CcSEcCtD
Nicotine—Mental disorder—Epirubicin—hematologic cancer	1.94e-05	0.000116	CcSEcCtD
Nicotine—Rash—Cisplatin—hematologic cancer	1.93e-05	0.000115	CcSEcCtD
Nicotine—Dermatitis—Cisplatin—hematologic cancer	1.93e-05	0.000115	CcSEcCtD
Nicotine—Erythema—Epirubicin—hematologic cancer	1.93e-05	0.000115	CcSEcCtD
Nicotine—Diarrhoea—Etoposide—hematologic cancer	1.92e-05	0.000114	CcSEcCtD
Nicotine—Ill-defined disorder—Methotrexate—hematologic cancer	1.91e-05	0.000114	CcSEcCtD
Nicotine—Feeling abnormal—Betamethasone—hematologic cancer	1.9e-05	0.000113	CcSEcCtD
Nicotine—Feeling abnormal—Dexamethasone—hematologic cancer	1.9e-05	0.000113	CcSEcCtD
Nicotine—Flushing—Doxorubicin—hematologic cancer	1.9e-05	0.000113	CcSEcCtD
Nicotine—Cardiac disorder—Doxorubicin—hematologic cancer	1.9e-05	0.000113	CcSEcCtD
Nicotine—Flatulence—Epirubicin—hematologic cancer	1.9e-05	0.000113	CcSEcCtD
Nicotine—Tension—Epirubicin—hematologic cancer	1.89e-05	0.000113	CcSEcCtD
Nicotine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.89e-05	0.000113	CcSEcCtD
Nicotine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.89e-05	0.000113	CcSEcCtD
Nicotine—Dysgeusia—Epirubicin—hematologic cancer	1.89e-05	0.000113	CcSEcCtD
Nicotine—Hypersensitivity—Triamcinolone—hematologic cancer	1.88e-05	0.000112	CcSEcCtD
Nicotine—Nervousness—Epirubicin—hematologic cancer	1.87e-05	0.000112	CcSEcCtD
Nicotine—Back pain—Epirubicin—hematologic cancer	1.86e-05	0.000111	CcSEcCtD
Nicotine—Malaise—Methotrexate—hematologic cancer	1.86e-05	0.000111	CcSEcCtD
Nicotine—Dizziness—Etoposide—hematologic cancer	1.86e-05	0.000111	CcSEcCtD
Nicotine—Muscle spasms—Epirubicin—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Nicotine—Immune system disorder—Doxorubicin—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Nicotine—Vertigo—Methotrexate—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Nicotine—Mediastinal disorder—Doxorubicin—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Nicotine—Urticaria—Betamethasone—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Nicotine—Urticaria—Dexamethasone—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Nicotine—Dizziness—Prednisolone—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Nicotine—Arrhythmia—Doxorubicin—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Nicotine—Asthenia—Triamcinolone—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Nicotine—Body temperature increased—Betamethasone—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Nicotine—Abdominal pain—Dexamethasone—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Nicotine—Abdominal pain—Betamethasone—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Nicotine—Body temperature increased—Dexamethasone—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Nicotine—Nausea—Cisplatin—hematologic cancer	1.82e-05	0.000108	CcSEcCtD
Nicotine—Insomnia—Prednisone—hematologic cancer	1.82e-05	0.000108	CcSEcCtD
Nicotine—Paraesthesia—Prednisone—hematologic cancer	1.81e-05	0.000108	CcSEcCtD
Nicotine—Pruritus—Triamcinolone—hematologic cancer	1.8e-05	0.000107	CcSEcCtD
Nicotine—Cough—Methotrexate—hematologic cancer	1.8e-05	0.000107	CcSEcCtD
Nicotine—Mental disorder—Doxorubicin—hematologic cancer	1.79e-05	0.000107	CcSEcCtD
Nicotine—Ill-defined disorder—Epirubicin—hematologic cancer	1.79e-05	0.000107	CcSEcCtD
Nicotine—Convulsion—Methotrexate—hematologic cancer	1.78e-05	0.000106	CcSEcCtD
Nicotine—Vomiting—Etoposide—hematologic cancer	1.78e-05	0.000106	CcSEcCtD
Nicotine—Erythema—Doxorubicin—hematologic cancer	1.78e-05	0.000106	CcSEcCtD
Nicotine—Agitation—Epirubicin—hematologic cancer	1.77e-05	0.000106	CcSEcCtD
Nicotine—Dyspepsia—Prednisone—hematologic cancer	1.77e-05	0.000106	CcSEcCtD
Nicotine—Rash—Etoposide—hematologic cancer	1.77e-05	0.000106	CcSEcCtD
Nicotine—Dermatitis—Etoposide—hematologic cancer	1.77e-05	0.000105	CcSEcCtD
Nicotine—Headache—Etoposide—hematologic cancer	1.76e-05	0.000105	CcSEcCtD
Nicotine—Flatulence—Doxorubicin—hematologic cancer	1.76e-05	0.000105	CcSEcCtD
Nicotine—Arthralgia—Methotrexate—hematologic cancer	1.75e-05	0.000105	CcSEcCtD
Nicotine—Chest pain—Methotrexate—hematologic cancer	1.75e-05	0.000105	CcSEcCtD
Nicotine—Myalgia—Methotrexate—hematologic cancer	1.75e-05	0.000105	CcSEcCtD
Nicotine—Tension—Doxorubicin—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Nicotine—Dysgeusia—Doxorubicin—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Nicotine—Rash—Prednisolone—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Nicotine—Dermatitis—Prednisolone—hematologic cancer	1.74e-05	0.000104	CcSEcCtD
Nicotine—Malaise—Epirubicin—hematologic cancer	1.74e-05	0.000104	CcSEcCtD
Nicotine—Fatigue—Prednisone—hematologic cancer	1.73e-05	0.000103	CcSEcCtD
Nicotine—Headache—Prednisolone—hematologic cancer	1.73e-05	0.000103	CcSEcCtD
Nicotine—Discomfort—Methotrexate—hematologic cancer	1.73e-05	0.000103	CcSEcCtD
Nicotine—Nervousness—Doxorubicin—hematologic cancer	1.73e-05	0.000103	CcSEcCtD
Nicotine—Vertigo—Epirubicin—hematologic cancer	1.73e-05	0.000103	CcSEcCtD
Nicotine—Syncope—Epirubicin—hematologic cancer	1.73e-05	0.000103	CcSEcCtD
Nicotine—Back pain—Doxorubicin—hematologic cancer	1.73e-05	0.000103	CcSEcCtD
Nicotine—Constipation—Prednisone—hematologic cancer	1.72e-05	0.000103	CcSEcCtD
Nicotine—Muscle spasms—Doxorubicin—hematologic cancer	1.71e-05	0.000102	CcSEcCtD
Nicotine—Palpitations—Epirubicin—hematologic cancer	1.7e-05	0.000102	CcSEcCtD
Nicotine—Confusional state—Methotrexate—hematologic cancer	1.69e-05	0.000101	CcSEcCtD
Nicotine—Loss of consciousness—Epirubicin—hematologic cancer	1.69e-05	0.000101	CcSEcCtD
Nicotine—Dizziness—Triamcinolone—hematologic cancer	1.68e-05	0.0001	CcSEcCtD
Nicotine—Cough—Epirubicin—hematologic cancer	1.68e-05	0.0001	CcSEcCtD
Nicotine—Anaphylactic shock—Methotrexate—hematologic cancer	1.68e-05	0.0001	CcSEcCtD
Nicotine—Convulsion—Epirubicin—hematologic cancer	1.67e-05	9.96e-05	CcSEcCtD
Nicotine—Nausea—Etoposide—hematologic cancer	1.67e-05	9.94e-05	CcSEcCtD
Nicotine—Hypertension—Epirubicin—hematologic cancer	1.66e-05	9.92e-05	CcSEcCtD
Nicotine—Feeling abnormal—Prednisone—hematologic cancer	1.66e-05	9.88e-05	CcSEcCtD
Nicotine—Asthenia—Betamethasone—hematologic cancer	1.66e-05	9.88e-05	CcSEcCtD
Nicotine—Asthenia—Dexamethasone—hematologic cancer	1.66e-05	9.88e-05	CcSEcCtD
Nicotine—Ill-defined disorder—Doxorubicin—hematologic cancer	1.65e-05	9.87e-05	CcSEcCtD
Nicotine—Nervous system disorder—Methotrexate—hematologic cancer	1.65e-05	9.83e-05	CcSEcCtD
Nicotine—Gastrointestinal pain—Prednisone—hematologic cancer	1.64e-05	9.81e-05	CcSEcCtD
Nicotine—Nausea—Prednisolone—hematologic cancer	1.64e-05	9.8e-05	CcSEcCtD
Nicotine—Chest pain—Epirubicin—hematologic cancer	1.64e-05	9.78e-05	CcSEcCtD
Nicotine—Arthralgia—Epirubicin—hematologic cancer	1.64e-05	9.78e-05	CcSEcCtD
Nicotine—Myalgia—Epirubicin—hematologic cancer	1.64e-05	9.78e-05	CcSEcCtD
Nicotine—Agitation—Doxorubicin—hematologic cancer	1.64e-05	9.77e-05	CcSEcCtD
Nicotine—Anxiety—Epirubicin—hematologic cancer	1.64e-05	9.75e-05	CcSEcCtD
Nicotine—Pruritus—Dexamethasone—hematologic cancer	1.63e-05	9.74e-05	CcSEcCtD
Nicotine—Pruritus—Betamethasone—hematologic cancer	1.63e-05	9.74e-05	CcSEcCtD
Nicotine—Hyperhidrosis—Methotrexate—hematologic cancer	1.62e-05	9.69e-05	CcSEcCtD
Nicotine—Discomfort—Epirubicin—hematologic cancer	1.62e-05	9.67e-05	CcSEcCtD
Nicotine—Vomiting—Triamcinolone—hematologic cancer	1.62e-05	9.65e-05	CcSEcCtD
Nicotine—Malaise—Doxorubicin—hematologic cancer	1.61e-05	9.59e-05	CcSEcCtD
Nicotine—Rash—Triamcinolone—hematologic cancer	1.6e-05	9.57e-05	CcSEcCtD
Nicotine—Dry mouth—Epirubicin—hematologic cancer	1.6e-05	9.57e-05	CcSEcCtD
Nicotine—Dermatitis—Triamcinolone—hematologic cancer	1.6e-05	9.56e-05	CcSEcCtD
Nicotine—Vertigo—Doxorubicin—hematologic cancer	1.6e-05	9.55e-05	CcSEcCtD
Nicotine—Syncope—Doxorubicin—hematologic cancer	1.6e-05	9.54e-05	CcSEcCtD
Nicotine—Urticaria—Prednisone—hematologic cancer	1.6e-05	9.53e-05	CcSEcCtD
Nicotine—Headache—Triamcinolone—hematologic cancer	1.59e-05	9.51e-05	CcSEcCtD
Nicotine—Abdominal pain—Prednisone—hematologic cancer	1.59e-05	9.48e-05	CcSEcCtD
Nicotine—Body temperature increased—Prednisone—hematologic cancer	1.59e-05	9.48e-05	CcSEcCtD
Nicotine—Confusional state—Epirubicin—hematologic cancer	1.59e-05	9.46e-05	CcSEcCtD
Nicotine—Diarrhoea—Betamethasone—hematologic cancer	1.58e-05	9.42e-05	CcSEcCtD
Nicotine—Diarrhoea—Dexamethasone—hematologic cancer	1.58e-05	9.42e-05	CcSEcCtD
Nicotine—Palpitations—Doxorubicin—hematologic cancer	1.58e-05	9.4e-05	CcSEcCtD
Nicotine—Oedema—Epirubicin—hematologic cancer	1.57e-05	9.38e-05	CcSEcCtD
Nicotine—Anaphylactic shock—Epirubicin—hematologic cancer	1.57e-05	9.38e-05	CcSEcCtD
Nicotine—Hypotension—Methotrexate—hematologic cancer	1.57e-05	9.37e-05	CcSEcCtD
Nicotine—Loss of consciousness—Doxorubicin—hematologic cancer	1.57e-05	9.35e-05	CcSEcCtD
Nicotine—Cough—Doxorubicin—hematologic cancer	1.56e-05	9.28e-05	CcSEcCtD
Nicotine—Shock—Epirubicin—hematologic cancer	1.55e-05	9.23e-05	CcSEcCtD
Nicotine—Convulsion—Doxorubicin—hematologic cancer	1.55e-05	9.21e-05	CcSEcCtD
Nicotine—Nervous system disorder—Epirubicin—hematologic cancer	1.54e-05	9.2e-05	CcSEcCtD
Nicotine—Hypertension—Doxorubicin—hematologic cancer	1.54e-05	9.18e-05	CcSEcCtD
Nicotine—Tachycardia—Epirubicin—hematologic cancer	1.54e-05	9.15e-05	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.53e-05	9.13e-05	CcSEcCtD
Nicotine—Dizziness—Betamethasone—hematologic cancer	1.53e-05	9.11e-05	CcSEcCtD
Nicotine—Dizziness—Dexamethasone—hematologic cancer	1.53e-05	9.11e-05	CcSEcCtD
Nicotine—Hyperhidrosis—Epirubicin—hematologic cancer	1.52e-05	9.07e-05	CcSEcCtD
Nicotine—Insomnia—Methotrexate—hematologic cancer	1.52e-05	9.07e-05	CcSEcCtD
Nicotine—Chest pain—Doxorubicin—hematologic cancer	1.52e-05	9.05e-05	CcSEcCtD
Nicotine—Arthralgia—Doxorubicin—hematologic cancer	1.52e-05	9.05e-05	CcSEcCtD
Nicotine—Myalgia—Doxorubicin—hematologic cancer	1.52e-05	9.05e-05	CcSEcCtD
Nicotine—Anxiety—Doxorubicin—hematologic cancer	1.51e-05	9.02e-05	CcSEcCtD
Nicotine—Nausea—Triamcinolone—hematologic cancer	1.51e-05	9.02e-05	CcSEcCtD
Nicotine—Paraesthesia—Methotrexate—hematologic cancer	1.51e-05	9e-05	CcSEcCtD
Nicotine—Discomfort—Doxorubicin—hematologic cancer	1.5e-05	8.94e-05	CcSEcCtD
Nicotine—Dyspnoea—Methotrexate—hematologic cancer	1.5e-05	8.94e-05	CcSEcCtD
Nicotine—Somnolence—Methotrexate—hematologic cancer	1.49e-05	8.91e-05	CcSEcCtD
Nicotine—Dry mouth—Doxorubicin—hematologic cancer	1.48e-05	8.85e-05	CcSEcCtD
Nicotine—Hypersensitivity—Prednisone—hematologic cancer	1.48e-05	8.84e-05	CcSEcCtD
Nicotine—Dyspepsia—Methotrexate—hematologic cancer	1.48e-05	8.82e-05	CcSEcCtD
Nicotine—Hypotension—Epirubicin—hematologic cancer	1.47e-05	8.76e-05	CcSEcCtD
Nicotine—Vomiting—Dexamethasone—hematologic cancer	1.47e-05	8.76e-05	CcSEcCtD
Nicotine—Vomiting—Betamethasone—hematologic cancer	1.47e-05	8.76e-05	CcSEcCtD
Nicotine—Confusional state—Doxorubicin—hematologic cancer	1.47e-05	8.75e-05	CcSEcCtD
Nicotine—Rash—Dexamethasone—hematologic cancer	1.46e-05	8.68e-05	CcSEcCtD
Nicotine—Rash—Betamethasone—hematologic cancer	1.46e-05	8.68e-05	CcSEcCtD
Nicotine—Anaphylactic shock—Doxorubicin—hematologic cancer	1.46e-05	8.68e-05	CcSEcCtD
Nicotine—Oedema—Doxorubicin—hematologic cancer	1.46e-05	8.68e-05	CcSEcCtD
Nicotine—Dermatitis—Dexamethasone—hematologic cancer	1.45e-05	8.67e-05	CcSEcCtD
Nicotine—Dermatitis—Betamethasone—hematologic cancer	1.45e-05	8.67e-05	CcSEcCtD
Nicotine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.45e-05	8.65e-05	CcSEcCtD
Nicotine—Fatigue—Methotrexate—hematologic cancer	1.45e-05	8.64e-05	CcSEcCtD
Nicotine—Headache—Betamethasone—hematologic cancer	1.45e-05	8.63e-05	CcSEcCtD
Nicotine—Headache—Dexamethasone—hematologic cancer	1.45e-05	8.63e-05	CcSEcCtD
Nicotine—Asthenia—Prednisone—hematologic cancer	1.44e-05	8.6e-05	CcSEcCtD
Nicotine—Pain—Methotrexate—hematologic cancer	1.44e-05	8.57e-05	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.43e-05	8.55e-05	CcSEcCtD
Nicotine—Shock—Doxorubicin—hematologic cancer	1.43e-05	8.54e-05	CcSEcCtD
Nicotine—Nervous system disorder—Doxorubicin—hematologic cancer	1.43e-05	8.51e-05	CcSEcCtD
Nicotine—Pruritus—Prednisone—hematologic cancer	1.42e-05	8.48e-05	CcSEcCtD
Nicotine—Insomnia—Epirubicin—hematologic cancer	1.42e-05	8.48e-05	CcSEcCtD
Nicotine—Tachycardia—Doxorubicin—hematologic cancer	1.42e-05	8.47e-05	CcSEcCtD
Nicotine—Paraesthesia—Epirubicin—hematologic cancer	1.41e-05	8.42e-05	CcSEcCtD
Nicotine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.41e-05	8.39e-05	CcSEcCtD
Nicotine—Dyspnoea—Epirubicin—hematologic cancer	1.4e-05	8.36e-05	CcSEcCtD
Nicotine—Somnolence—Epirubicin—hematologic cancer	1.4e-05	8.34e-05	CcSEcCtD
Nicotine—Feeling abnormal—Methotrexate—hematologic cancer	1.39e-05	8.26e-05	CcSEcCtD
Nicotine—Dyspepsia—Epirubicin—hematologic cancer	1.38e-05	8.26e-05	CcSEcCtD
Nicotine—Diarrhoea—Prednisone—hematologic cancer	1.38e-05	8.21e-05	CcSEcCtD
Nicotine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.37e-05	8.2e-05	CcSEcCtD
Nicotine—Nausea—Dexamethasone—hematologic cancer	1.37e-05	8.18e-05	CcSEcCtD
Nicotine—Nausea—Betamethasone—hematologic cancer	1.37e-05	8.18e-05	CcSEcCtD
Nicotine—Hypotension—Doxorubicin—hematologic cancer	1.36e-05	8.11e-05	CcSEcCtD
Nicotine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.36e-05	8.1e-05	CcSEcCtD
Nicotine—Fatigue—Epirubicin—hematologic cancer	1.36e-05	8.09e-05	CcSEcCtD
Nicotine—Pain—Epirubicin—hematologic cancer	1.35e-05	8.02e-05	CcSEcCtD
Nicotine—Constipation—Epirubicin—hematologic cancer	1.35e-05	8.02e-05	CcSEcCtD
Nicotine—Urticaria—Methotrexate—hematologic cancer	1.34e-05	7.96e-05	CcSEcCtD
Nicotine—Dizziness—Prednisone—hematologic cancer	1.33e-05	7.93e-05	CcSEcCtD
Nicotine—Body temperature increased—Methotrexate—hematologic cancer	1.33e-05	7.92e-05	CcSEcCtD
Nicotine—Abdominal pain—Methotrexate—hematologic cancer	1.33e-05	7.92e-05	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.33e-05	7.91e-05	CcSEcCtD
Nicotine—Insomnia—Doxorubicin—hematologic cancer	1.32e-05	7.85e-05	CcSEcCtD
Nicotine—Paraesthesia—Doxorubicin—hematologic cancer	1.31e-05	7.79e-05	CcSEcCtD
Nicotine—Dyspnoea—Doxorubicin—hematologic cancer	1.3e-05	7.74e-05	CcSEcCtD
Nicotine—Feeling abnormal—Epirubicin—hematologic cancer	1.3e-05	7.73e-05	CcSEcCtD
Nicotine—Somnolence—Doxorubicin—hematologic cancer	1.29e-05	7.72e-05	CcSEcCtD
Nicotine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.29e-05	7.67e-05	CcSEcCtD
Nicotine—Dyspepsia—Doxorubicin—hematologic cancer	1.28e-05	7.64e-05	CcSEcCtD
Nicotine—Vomiting—Prednisone—hematologic cancer	1.28e-05	7.63e-05	CcSEcCtD
Nicotine—Rash—Prednisone—hematologic cancer	1.27e-05	7.56e-05	CcSEcCtD
Nicotine—Dermatitis—Prednisone—hematologic cancer	1.27e-05	7.55e-05	CcSEcCtD
Nicotine—Headache—Prednisone—hematologic cancer	1.26e-05	7.51e-05	CcSEcCtD
Nicotine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.26e-05	7.49e-05	CcSEcCtD
Nicotine—Fatigue—Doxorubicin—hematologic cancer	1.25e-05	7.48e-05	CcSEcCtD
Nicotine—Urticaria—Epirubicin—hematologic cancer	1.25e-05	7.45e-05	CcSEcCtD
Nicotine—Pain—Doxorubicin—hematologic cancer	1.24e-05	7.42e-05	CcSEcCtD
Nicotine—Constipation—Doxorubicin—hematologic cancer	1.24e-05	7.42e-05	CcSEcCtD
Nicotine—Body temperature increased—Epirubicin—hematologic cancer	1.24e-05	7.41e-05	CcSEcCtD
Nicotine—Abdominal pain—Epirubicin—hematologic cancer	1.24e-05	7.41e-05	CcSEcCtD
Nicotine—Hypersensitivity—Methotrexate—hematologic cancer	1.24e-05	7.38e-05	CcSEcCtD
Nicotine—Asthenia—Methotrexate—hematologic cancer	1.21e-05	7.19e-05	CcSEcCtD
Nicotine—Feeling abnormal—Doxorubicin—hematologic cancer	1.2e-05	7.15e-05	CcSEcCtD
Nicotine—Nausea—Prednisone—hematologic cancer	1.19e-05	7.12e-05	CcSEcCtD
Nicotine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.19e-05	7.1e-05	CcSEcCtD
Nicotine—Pruritus—Methotrexate—hematologic cancer	1.19e-05	7.09e-05	CcSEcCtD
Nicotine—Hypersensitivity—Epirubicin—hematologic cancer	1.16e-05	6.91e-05	CcSEcCtD
Nicotine—Urticaria—Doxorubicin—hematologic cancer	1.16e-05	6.89e-05	CcSEcCtD
Nicotine—Abdominal pain—Doxorubicin—hematologic cancer	1.15e-05	6.86e-05	CcSEcCtD
Nicotine—Body temperature increased—Doxorubicin—hematologic cancer	1.15e-05	6.86e-05	CcSEcCtD
Nicotine—Diarrhoea—Methotrexate—hematologic cancer	1.15e-05	6.86e-05	CcSEcCtD
Nicotine—Asthenia—Epirubicin—hematologic cancer	1.13e-05	6.73e-05	CcSEcCtD
Nicotine—Pruritus—Epirubicin—hematologic cancer	1.11e-05	6.64e-05	CcSEcCtD
Nicotine—Dizziness—Methotrexate—hematologic cancer	1.11e-05	6.63e-05	CcSEcCtD
Nicotine—Diarrhoea—Epirubicin—hematologic cancer	1.08e-05	6.42e-05	CcSEcCtD
Nicotine—Hypersensitivity—Doxorubicin—hematologic cancer	1.07e-05	6.39e-05	CcSEcCtD
Nicotine—Vomiting—Methotrexate—hematologic cancer	1.07e-05	6.37e-05	CcSEcCtD
Nicotine—Rash—Methotrexate—hematologic cancer	1.06e-05	6.32e-05	CcSEcCtD
Nicotine—Dermatitis—Methotrexate—hematologic cancer	1.06e-05	6.31e-05	CcSEcCtD
Nicotine—Headache—Methotrexate—hematologic cancer	1.05e-05	6.28e-05	CcSEcCtD
Nicotine—Asthenia—Doxorubicin—hematologic cancer	1.04e-05	6.23e-05	CcSEcCtD
Nicotine—Dizziness—Epirubicin—hematologic cancer	1.04e-05	6.2e-05	CcSEcCtD
Nicotine—Pruritus—Doxorubicin—hematologic cancer	1.03e-05	6.14e-05	CcSEcCtD
Nicotine—Vomiting—Epirubicin—hematologic cancer	1e-05	5.96e-05	CcSEcCtD
Nicotine—Nausea—Methotrexate—hematologic cancer	9.98e-06	5.95e-05	CcSEcCtD
Nicotine—Diarrhoea—Doxorubicin—hematologic cancer	9.96e-06	5.94e-05	CcSEcCtD
Nicotine—Rash—Epirubicin—hematologic cancer	9.92e-06	5.91e-05	CcSEcCtD
Nicotine—Dermatitis—Epirubicin—hematologic cancer	9.91e-06	5.91e-05	CcSEcCtD
Nicotine—Headache—Epirubicin—hematologic cancer	9.85e-06	5.88e-05	CcSEcCtD
Nicotine—Dizziness—Doxorubicin—hematologic cancer	9.62e-06	5.74e-05	CcSEcCtD
Nicotine—Nausea—Epirubicin—hematologic cancer	9.34e-06	5.57e-05	CcSEcCtD
Nicotine—Vomiting—Doxorubicin—hematologic cancer	9.25e-06	5.52e-05	CcSEcCtD
Nicotine—Rash—Doxorubicin—hematologic cancer	9.18e-06	5.47e-05	CcSEcCtD
Nicotine—Dermatitis—Doxorubicin—hematologic cancer	9.17e-06	5.47e-05	CcSEcCtD
Nicotine—Headache—Doxorubicin—hematologic cancer	9.12e-06	5.44e-05	CcSEcCtD
Nicotine—Nausea—Doxorubicin—hematologic cancer	8.65e-06	5.16e-05	CcSEcCtD
Nicotine—CYP19A1—Metabolism—ALB—hematologic cancer	2.01e-06	2.61e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CG—hematologic cancer	2e-06	2.6e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—NCOR1—hematologic cancer	2e-06	2.6e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GSTM1—hematologic cancer	2e-06	2.6e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ADCY7—hematologic cancer	2e-06	2.6e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NCOA3—hematologic cancer	2e-06	2.6e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.99e-06	2.59e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NUP214—hematologic cancer	1.98e-06	2.58e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ACP5—hematologic cancer	1.98e-06	2.57e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CA9—hematologic cancer	1.98e-06	2.57e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NQO1—hematologic cancer	1.97e-06	2.56e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CD44—hematologic cancer	1.97e-06	2.56e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3R1—hematologic cancer	1.97e-06	2.56e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.96e-06	2.55e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GSTM1—hematologic cancer	1.96e-06	2.54e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—NCOR1—hematologic cancer	1.96e-06	2.54e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.95e-06	2.54e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.94e-06	2.53e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ABCG2—hematologic cancer	1.94e-06	2.53e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—MTR—hematologic cancer	1.94e-06	2.53e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.93e-06	2.51e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3R1—hematologic cancer	1.92e-06	2.49e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.91e-06	2.48e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ENO2—hematologic cancer	1.91e-06	2.48e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ABCB1—hematologic cancer	1.9e-06	2.47e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.87e-06	2.43e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CG—hematologic cancer	1.87e-06	2.43e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYCS—hematologic cancer	1.86e-06	2.42e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—IDH1—hematologic cancer	1.86e-06	2.42e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CREBBP—hematologic cancer	1.86e-06	2.42e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	1.85e-06	2.41e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTT1—hematologic cancer	1.85e-06	2.4e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSTM1—hematologic cancer	1.85e-06	2.4e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—NCOR1—hematologic cancer	1.85e-06	2.4e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTP1—hematologic cancer	1.84e-06	2.39e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CG—hematologic cancer	1.84e-06	2.39e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.84e-06	2.39e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TXN—hematologic cancer	1.84e-06	2.39e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.84e-06	2.39e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.82e-06	2.37e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3CB—hematologic cancer	1.82e-06	2.36e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NQO1—hematologic cancer	1.81e-06	2.36e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CD44—hematologic cancer	1.81e-06	2.36e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SDC1—hematologic cancer	1.81e-06	2.35e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.8e-06	2.34e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NQO1—hematologic cancer	1.8e-06	2.34e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CD44—hematologic cancer	1.8e-06	2.34e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.78e-06	2.32e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3CB—hematologic cancer	1.77e-06	2.3e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—MTHFR—hematologic cancer	1.77e-06	2.3e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PIK3CA—hematologic cancer	1.76e-06	2.29e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CD—hematologic cancer	1.76e-06	2.29e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.76e-06	2.29e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ABCB1—hematologic cancer	1.74e-06	2.27e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ALB—hematologic cancer	1.74e-06	2.26e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CREBBP—hematologic cancer	1.73e-06	2.25e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—MTHFR—hematologic cancer	1.73e-06	2.25e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.73e-06	2.25e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.73e-06	2.24e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYCS—hematologic cancer	1.72e-06	2.23e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CREBBP—hematologic cancer	1.71e-06	2.22e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.7e-06	2.22e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.7e-06	2.21e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYCS—hematologic cancer	1.7e-06	2.21e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.69e-06	2.2e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.69e-06	2.2e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.69e-06	2.2e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.68e-06	2.19e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.68e-06	2.19e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.67e-06	2.17e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3R1—hematologic cancer	1.66e-06	2.16e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.64e-06	2.14e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CD—hematologic cancer	1.64e-06	2.13e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.64e-06	2.13e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—MTHFR—hematologic cancer	1.63e-06	2.12e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.63e-06	2.12e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ALB—hematologic cancer	1.62e-06	2.11e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CD—hematologic cancer	1.62e-06	2.1e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ALB—hematologic cancer	1.6e-06	2.08e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.59e-06	2.07e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NUP98—hematologic cancer	1.59e-06	2.06e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTEN—hematologic cancer	1.57e-06	2.04e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.56e-06	2.02e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3R1—hematologic cancer	1.55e-06	2.02e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.54e-06	2e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.54e-06	2e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CD44—hematologic cancer	1.54e-06	2e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NQO1—hematologic cancer	1.54e-06	2e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CB—hematologic cancer	1.54e-06	2e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NUP214—hematologic cancer	1.53e-06	1.99e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTEN—hematologic cancer	1.53e-06	1.99e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3R1—hematologic cancer	1.53e-06	1.99e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.52e-06	1.98e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.51e-06	1.97e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.51e-06	1.96e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.51e-06	1.96e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.5e-06	1.95e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—MTR—hematologic cancer	1.5e-06	1.95e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.5e-06	1.95e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.5e-06	1.95e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—EP300—hematologic cancer	1.5e-06	1.94e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.5e-06	1.94e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PIK3CA—hematologic cancer	1.49e-06	1.94e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	1.48e-06	1.93e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ENO2—hematologic cancer	1.47e-06	1.91e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—EP300—hematologic cancer	1.46e-06	1.9e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	1.45e-06	1.89e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYCS—hematologic cancer	1.45e-06	1.89e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.45e-06	1.88e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.44e-06	1.88e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—AKT1—hematologic cancer	1.44e-06	1.87e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.44e-06	1.87e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CB—hematologic cancer	1.43e-06	1.86e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.43e-06	1.86e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.43e-06	1.85e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.42e-06	1.84e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CB—hematologic cancer	1.41e-06	1.83e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SDC1—hematologic cancer	1.39e-06	1.81e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.39e-06	1.81e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.39e-06	1.81e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.38e-06	1.79e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.38e-06	1.79e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CREBBP—hematologic cancer	1.38e-06	1.79e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CG—hematologic cancer	1.37e-06	1.78e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CREBBP—hematologic cancer	1.35e-06	1.75e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.33e-06	1.74e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTEN—hematologic cancer	1.33e-06	1.72e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.32e-06	1.71e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	1.3e-06	1.7e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.3e-06	1.69e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ALB—hematologic cancer	1.29e-06	1.67e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.28e-06	1.66e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	1.28e-06	1.66e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CREBBP—hematologic cancer	1.27e-06	1.65e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—EP300—hematologic cancer	1.27e-06	1.64e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ALB—hematologic cancer	1.26e-06	1.64e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.26e-06	1.63e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.24e-06	1.61e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTEN—hematologic cancer	1.24e-06	1.61e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	1.23e-06	1.6e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.23e-06	1.6e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—AKT1—hematologic cancer	1.22e-06	1.58e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTEN—hematologic cancer	1.22e-06	1.58e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.22e-06	1.58e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.21e-06	1.58e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	1.21e-06	1.57e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CD—hematologic cancer	1.2e-06	1.57e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ALB—hematologic cancer	1.19e-06	1.55e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NQO1—hematologic cancer	1.19e-06	1.54e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CD44—hematologic cancer	1.19e-06	1.54e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—EP300—hematologic cancer	1.18e-06	1.53e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.18e-06	1.53e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.18e-06	1.53e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.18e-06	1.53e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.17e-06	1.51e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—EP300—hematologic cancer	1.16e-06	1.51e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3R1—hematologic cancer	1.14e-06	1.48e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.14e-06	1.48e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.12e-06	1.46e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.12e-06	1.46e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.11e-06	1.45e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	1.11e-06	1.45e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3CA—hematologic cancer	1.11e-06	1.44e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.1e-06	1.44e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ALB—hematologic cancer	1.09e-06	1.42e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3CA—hematologic cancer	1.08e-06	1.4e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.07e-06	1.39e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.04e-06	1.36e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.03e-06	1.34e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.02e-06	1.33e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTP1—hematologic cancer	9.88e-07	1.28e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	9.86e-07	1.28e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTEN—hematologic cancer	9.83e-07	1.28e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ALB—hematologic cancer	9.73e-07	1.27e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	9.63e-07	1.25e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTEN—hematologic cancer	9.63e-07	1.25e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CREBBP—hematologic cancer	9.56e-07	1.24e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CREBBP—hematologic cancer	9.48e-07	1.23e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—EP300—hematologic cancer	9.37e-07	1.22e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	9.36e-07	1.22e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ABCB1—hematologic cancer	9.36e-07	1.22e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	9.31e-07	1.21e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—EP300—hematologic cancer	9.18e-07	1.19e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.17e-07	1.19e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NCOR1—hematologic cancer	9.08e-07	1.18e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTM1—hematologic cancer	9.08e-07	1.18e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTEN—hematologic cancer	9.08e-07	1.18e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	9.07e-07	1.18e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—AKT1—hematologic cancer	9.04e-07	1.18e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	8.99e-07	1.17e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ALB—hematologic cancer	8.95e-07	1.16e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ALB—hematologic cancer	8.88e-07	1.15e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—AKT1—hematologic cancer	8.82e-07	1.15e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	8.74e-07	1.14e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	8.72e-07	1.13e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—EP300—hematologic cancer	8.65e-07	1.13e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	8.59e-07	1.12e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CA—hematologic cancer	8.59e-07	1.12e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	8.56e-07	1.11e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	8.49e-07	1.1e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTEN—hematologic cancer	8.32e-07	1.08e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CREBBP—hematologic cancer	8.1e-07	1.05e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—MTHFR—hematologic cancer	8.03e-07	1.04e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—EP300—hematologic cancer	7.93e-07	1.03e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	7.9e-07	1.03e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	7.84e-07	1.02e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	7.68e-07	9.99e-06	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—AKT1—hematologic cancer	7.65e-07	9.94e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ALB—hematologic cancer	7.58e-07	9.86e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTEN—hematologic cancer	7.43e-07	9.65e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	7.25e-07	9.43e-06	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—AKT1—hematologic cancer	7.13e-07	9.26e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—EP300—hematologic cancer	7.08e-07	9.21e-06	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—AKT1—hematologic cancer	7.02e-07	9.12e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	6.93e-07	9.01e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTEN—hematologic cancer	6.83e-07	8.88e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	6.79e-07	8.83e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTEN—hematologic cancer	6.77e-07	8.8e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	6.74e-07	8.77e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	6.7e-07	8.7e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—EP300—hematologic cancer	6.51e-07	8.47e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—EP300—hematologic cancer	6.46e-07	8.39e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CA—hematologic cancer	6.4e-07	8.32e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CREBBP—hematologic cancer	6.25e-07	8.13e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	5.93e-07	7.71e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	5.87e-07	7.63e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ALB—hematologic cancer	5.85e-07	7.61e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTEN—hematologic cancer	5.79e-07	7.52e-06	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—AKT1—hematologic cancer	5.66e-07	7.36e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.6e-07	7.28e-06	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—AKT1—hematologic cancer	5.55e-07	7.21e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—EP300—hematologic cancer	5.52e-07	7.17e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	5.24e-07	6.81e-06	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—AKT1—hematologic cancer	5.23e-07	6.8e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	5.17e-07	6.72e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	4.82e-07	6.26e-06	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—AKT1—hematologic cancer	4.79e-07	6.23e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	4.78e-07	6.21e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTEN—hematologic cancer	4.47e-07	5.81e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—AKT1—hematologic cancer	4.28e-07	5.56e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—EP300—hematologic cancer	4.26e-07	5.54e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.08e-07	5.31e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—AKT1—hematologic cancer	3.94e-07	5.12e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—AKT1—hematologic cancer	3.9e-07	5.07e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—AKT1—hematologic cancer	3.33e-07	4.33e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.15e-07	4.1e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—AKT1—hematologic cancer	2.57e-07	3.35e-06	CbGpPWpGaD
